Biotech Values

[DewDiligence]

IDIX Insider Transactions During Past 24 Months

[Added Standring’s 11/11/09 option exercise.
See #msg-43558454 for current insider holdings.]


OPTION EXERCISES

David Standring, EVP Biology
11-Nov-2009 15,000 options @$1.00 (#msg-43558137)


PURCHASES

Ron Renaud, CFO
11-Mar-2008 15,000 shares @4.50-4.55

Doug Mayers, CMO
11-Mar-2008 30,000 shares @4.45

John Weidenbruch, Gen Counsel
11-Mar-2008 15,000 shares @4.52-4.59


SALES

JP Sommadossi, CEO
*16-Sep-2008 110,000 shares @8.00

*Transfer of shares to University of Alabama as
part of a previously announced legal settlement.


SEC links:
http://sec.gov/Archives/edgar/data/1093649/000120919109052601/xslF345X03/doc4.xml
http://sec.gov/Archives/edgar/data/1093649/000120919108052275/xslF345X03/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017195/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017843/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017844/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919106029333/xslF345X02/doc4.xml